156 related articles for article (PubMed ID: 37138020)
1. DNA polymerase gamma variants and hepatotoxicity during maintenance therapy of childhood acute lymphoblastic leukemia: is there a causal relationship?
Harju T; Hurme-Niiranen A; Suo-Palosaari M; Nygaard Nielsen S; Hinttala R; Schmiegelow K; Uusimaa J; Harila A; Niinimäki R
Pharmacogenomics J; 2023 Sep; 23(5):105-111. PubMed ID: 37138020
[TBL] [Abstract][Full Text] [Related]
2. Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy.
Hynynen J; Pokka T; Komulainen-Ebrahim J; Myllynen P; Kärppä M; Pylvänen L; Kälviäinen R; Sokka A; Jyrkilä A; Lähdetie J; Haataja L; Mäkitalo A; Ylikotila P; Eriksson K; Haapala P; Ansakorpi H; Hinttala R; Vieira P; Majamaa K; Rantala H; Uusimaa J
Epilepsia; 2018 Nov; 59(11):2125-2136. PubMed ID: 30255931
[TBL] [Abstract][Full Text] [Related]
3. [Association between polymorphism of NUDT15 gene and hepatotoxicity induced by 6-MP in children with acute lymphoblastic leukemia].
Wang X; Wang W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Dec; 38(12):1258-1261. PubMed ID: 34839520
[TBL] [Abstract][Full Text] [Related]
4. Methylated metabolites of 6-mercaptopurine are associated with hepatotoxicity.
Nygaard U; Toft N; Schmiegelow K
Clin Pharmacol Ther; 2004 Apr; 75(4):274-81. PubMed ID: 15060506
[TBL] [Abstract][Full Text] [Related]
5. Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy.
Adam de Beaumais T; Fakhoury M; Medard Y; Azougagh S; Zhang D; Yakouben K; Jacqz-Aigrain E
Br J Clin Pharmacol; 2011 Apr; 71(4):575-84. PubMed ID: 21395650
[TBL] [Abstract][Full Text] [Related]
6. Cooccurrence of Two Different Genetic Diseases: A Case of Valproic Acid Hepatotoxicity in Nicolaides-Baraitser Syndrome (SMARCA2 Mutation)-Due to a POLG1-Related Effect?
Hofmeister B; von Stülpnagel C; Berweck S; Abicht A; Kluger G; Weber P
Neuropediatrics; 2020 Feb; 51(1):49-52. PubMed ID: 31541998
[TBL] [Abstract][Full Text] [Related]
7. Assessment on the use of allopurinol to improve safety and efficacy of mercaptopurine in pediatric patients with Acute Lymphoblastic Leukemia and Lymphoma during maintenance therapy.
Barone T; Dandekar S; McKeone D; Mulieri K
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1987. PubMed ID: 38351548
[TBL] [Abstract][Full Text] [Related]
8. Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity.
Stewart JD; Horvath R; Baruffini E; Ferrero I; Bulst S; Watkins PB; Fontana RJ; Day CP; Chinnery PF
Hepatology; 2010 Nov; 52(5):1791-6. PubMed ID: 21038416
[TBL] [Abstract][Full Text] [Related]
9. Association Between Combined Presence of Hepatitis C Virus and Polymorphisms in Different Genes With Toxicities of Methotrexate and 6-Mercaptopurine in Children With Acute Lymphoblastic Leukemia.
Abdelaziz DH; Elhosseiny NM; Khaleel SA; Sabry NA; Attia AS; El-Sayed MH
Pediatr Blood Cancer; 2016 Sep; 63(9):1539-45. PubMed ID: 27163515
[TBL] [Abstract][Full Text] [Related]
10. Role of TPMT and ITPA variants in mercaptopurine disposition.
Gerbek T; Ebbesen M; Nersting J; Frandsen TL; Appell ML; Schmiegelow K
Cancer Chemother Pharmacol; 2018 Mar; 81(3):579-586. PubMed ID: 29387964
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to 6-MP toxicity conferred by a NUDT15 variant in Japanese children with acute lymphoblastic leukaemia.
Tanaka Y; Kato M; Hasegawa D; Urayama KY; Nakadate H; Kondoh K; Nakamura K; Koh K; Komiyama T; Manabe A
Br J Haematol; 2015 Oct; 171(1):109-15. PubMed ID: 26033531
[TBL] [Abstract][Full Text] [Related]
12. Use of allopurinol to reduce hepatotoxicity from 6-mercaptopurine (6-MP) in patients with acute lymphoblastic leukemia (ALL).
Stuckert AJ; Schafer ES; Bernhardt MB; Baxter P; Brackett J
Leuk Lymphoma; 2020 May; 61(5):1246-1249. PubMed ID: 31842647
[No Abstract] [Full Text] [Related]
13. Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocol.
Toksvang LN; Als-Nielsen B; Bacon C; Bertasiute R; Duarte X; Escherich G; Helgadottir EA; Johannsdottir IR; Jónsson ÓG; Kozlowski P; Langenskjöld C; Lepik K; Niinimäki R; Overgaard UM; Punab M; Räty R; Segers H; van der Sluis I; Smith OP; Strullu M; Vaitkevičienė G; Wik HS; Heyman M; Schmiegelow K
BMC Cancer; 2022 May; 22(1):483. PubMed ID: 35501736
[TBL] [Abstract][Full Text] [Related]
14. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial.
Nielsen SN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Hjalgrim LL; Schmiegelow K
Lancet Oncol; 2017 Apr; 18(4):515-524. PubMed ID: 28258828
[TBL] [Abstract][Full Text] [Related]
15. Fatal hepatotoxicity associated with 6-mercaptopurine therapy.
Laidlaw ST; Reilly JT; Suvarna SK
Postgrad Med J; 1995 Oct; 71(840):639. PubMed ID: 8545299
[No Abstract] [Full Text] [Related]
16. [Susceptibility to 6-mercaptopurine toxicity related with NUDT15 and ABCC4 variants in Japanese childhood acute lymphoblastic leukemia].
Tanaka Y
Rinsho Ketsueki; 2017; 58(8):950-956. PubMed ID: 28883280
[TBL] [Abstract][Full Text] [Related]
17. Hepatotoxicity During Maintenance Therapy and Prognosis in Children With Acute Lymphoblastic Leukemia.
Ebbesen MS; Nygaard U; Rosthøj S; Sørensen D; Nersting J; Vettenranta K; Wesenberg F; Kristinsson J; Harila-Saari A; Schmiegelow K
J Pediatr Hematol Oncol; 2017 Apr; 39(3):161-166. PubMed ID: 28060115
[TBL] [Abstract][Full Text] [Related]
18. Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
Zhou H; Li L; Yang P; Yang L; Zheng JE; Zhou Y; Han Y
BMC Cancer; 2018 May; 18(1):516. PubMed ID: 29720126
[TBL] [Abstract][Full Text] [Related]
19. Allele-specific polymerase chain reaction can determine the diplotype of NUDT15 variants in patients with childhood acute lymphoblastic Leukemia.
Yu CH; Chang YH; Wang DS; Jou ST; Lin CY; Lin KH; Lu MY; Wu KH; Cheng CN; Chang HH; Chou SW; Su MY; Ni YL; Xu PY; Lin DT; Lin SW; Chen HY; Yang YL
Sci Rep; 2023 Jan; 13(1):490. PubMed ID: 36627439
[TBL] [Abstract][Full Text] [Related]
20. Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1).
McFarland R; Hudson G; Taylor RW; Green SH; Hodges S; McKiernan PJ; Chinnery PF; Ramesh V
Arch Dis Child; 2008 Feb; 93(2):151-3. PubMed ID: 18208989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
